287 related articles for article (PubMed ID: 8301574)
1. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
Gully D; Labeeuw B; Boigegrain R; Oury-Donat F; Bachy A; Poncelet M; Steinberg R; Suaud-Chagny MF; Santucci V; Vita N; Pecceu F; Labbé-Jullié C; Kitabgi P; Soubrié P; Le Fur G; Maffrand JP
J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin receptor down-regulation induced by dexamethasone and forskolin in rat hypothalamic cultures is mediated by endogenous neurotensin.
Scarcériaux V; Souazé F; Bachelet CM; Forgez P; Bourdel E; Martinez J; Rostène W; Pélaprat D
J Neuroendocrinol; 1996 Aug; 8(8):587-93. PubMed ID: 8866245
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons.
Jomphe C; Lemelin PL; Okano H; Kobayashi K; Trudeau LE
Eur J Neurosci; 2006 Nov; 24(10):2789-800. PubMed ID: 17116165
[TBL] [Abstract][Full Text] [Related]
7. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin analogs [D-TYR11] and [D-PHE11]neurotensin resist degradation by brain peptidases in vitro and in vivo.
Checler F; Vincent JP; Kitabgi P
J Pharmacol Exp Ther; 1983 Dec; 227(3):743-8. PubMed ID: 6361231
[TBL] [Abstract][Full Text] [Related]
9. On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY.
Seebach D; Lukaszuk A; Patora-Komisarska K; Podwysocka D; Gardiner J; Ebert MO; Reubi JC; Cescato R; Waser B; Gmeiner P; Hübner H; Rougeot C
Chem Biodivers; 2011 May; 8(5):711-39. PubMed ID: 21560227
[TBL] [Abstract][Full Text] [Related]
10. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
[TBL] [Abstract][Full Text] [Related]
11. In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues.
Kokko KP; Hadden MK; Orwig KS; Mazella J; Dix TA
J Med Chem; 2003 Sep; 46(19):4141-8. PubMed ID: 12954066
[TBL] [Abstract][Full Text] [Related]
12. Effects of 5 daily injections of the neurotensin-mimetic NT69L on the expression of neurotensin receptors in rat brain.
Wang R; Boules M; Gollatz E; Williams K; Tiner W; Richelson E
Brain Res Mol Brain Res; 2005 Jul; 138(1):24-34. PubMed ID: 15878217
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
Hadden MK; Orwig KS; Kokko KP; Mazella J; Dix TA
Neuropharmacology; 2005 Dec; 49(8):1149-59. PubMed ID: 16095636
[TBL] [Abstract][Full Text] [Related]
14. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2.
Gendron L; Perron A; Payet MD; Gallo-Payet N; Sarret P; Beaudet A
Mol Pharmacol; 2004 Dec; 66(6):1421-30. PubMed ID: 15361549
[TBL] [Abstract][Full Text] [Related]
15. Reduced peptide bond pseudopeptide analogues of neurotensin.
Doulut S; Rodriguez M; Lugrin D; Vecchini F; Kitabgi P; Aumelas A; Martinez J
Pept Res; 1992; 5(1):30-8. PubMed ID: 1623301
[TBL] [Abstract][Full Text] [Related]
16. JMV 449: a pseudopeptide analogue of neurotensin-(8-13) with highly potent and long-lasting hypothermic and analgesic effects in the mouse.
Dubuc I; Costentin J; Doulut S; Rodriguez M; Martinez J; Kitabgi P
Eur J Pharmacol; 1992 Aug; 219(2):327-9. PubMed ID: 1425958
[TBL] [Abstract][Full Text] [Related]
17. Rapid desensitization of dopamine release induced by neurotensin and neurotensin fragments.
Faggin BM; Cubeddu LX
J Pharmacol Exp Ther; 1990 May; 253(2):812-8. PubMed ID: 2338657
[TBL] [Abstract][Full Text] [Related]
18. Bowel resection and neurotensin treatment. Histochemical study of neurotensin-like and somatostatin-like immunoreactivities and receptors.
Toledano A; Rodríguez-Arellano JJ; Gómez de Segura IA; De Miguel E; Martínez-Rodríguez R
Cell Mol Biol (Noisy-le-grand); 1996 Dec; 42(8):1145-58. PubMed ID: 8997519
[TBL] [Abstract][Full Text] [Related]
19. Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13).
Donato di Paola E; Cusack B; Yamada M; Richelson E
J Pharmacol Exp Ther; 1993 Jan; 264(1):1-5. PubMed ID: 8380855
[TBL] [Abstract][Full Text] [Related]
20. Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy.
Orwig KS; Lassetter MR; Hadden MK; Dix TA
J Med Chem; 2009 Apr; 52(7):1803-13. PubMed ID: 19290594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
